Fiuzat, M., Wojdyla, D., Whellan, D., Chiswell, K., Kitzman, D., Kraus, W., … O’Connor, C. M. (2011). Relationship of Beta-Blocker (BB) Dose with Outcomes in Ambulatory Heart Failure (HF) Patients with Systolic Dysfunction: Results from the HF-ACTION Trial. In CIRCULATION (Vol. 124). LIPPINCOTT WILLIAMS & WILKINS.

Fiuzat, Mona, Daniel Wojdyla, David Whellan, Karen Chiswell, Dalane Kitzman, William Kraus, Steven Keteyian, et al. “Relationship of Beta-Blocker (BB) Dose with Outcomes in Ambulatory Heart Failure (HF) Patients with Systolic Dysfunction: Results from the HF-ACTION Trial.” In CIRCULATION, Vol. 124. LIPPINCOTT WILLIAMS & WILKINS, 2011.

Fiuzat M, Wojdyla D, Whellan D, Chiswell K, Kitzman D, Kraus W, et al. Relationship of Beta-Blocker (BB) Dose with Outcomes in Ambulatory Heart Failure (HF) Patients with Systolic Dysfunction: Results from the HF-ACTION Trial. In: CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2011.

Fiuzat, Mona, et al. “Relationship of Beta-Blocker (BB) Dose with Outcomes in Ambulatory Heart Failure (HF) Patients with Systolic Dysfunction: Results from the HF-ACTION Trial.” CIRCULATION, vol. 124, no. 21, LIPPINCOTT WILLIAMS & WILKINS, 2011.

Fiuzat M, Wojdyla D, Whellan D, Chiswell K, Kitzman D, Kraus W, Keteyian S, Patterson H, Adams K, Fleg J, Pina I, O’Connor CM. Relationship of Beta-Blocker (BB) Dose with Outcomes in Ambulatory Heart Failure (HF) Patients with Systolic Dysfunction: Results from the HF-ACTION Trial. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2011.